The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing

BACKGROUND: Histone deacetylase inhibitors (HDACi) cause histone hyperacetylation and H3K4 hypermethylation in various cell types. They find clinical application as anti-epileptics and chemotherapeutic agents, but the pathways through which they operate remain unclear. Surprisingly, changes in gene...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Boudadi, Elsa, Stower, Hannah, Halsall, John A, Rutledge, Charlotte E, Leeb, Martin, Wutz, Anton, O’Neill, Laura P, Nightingale, Karl P, Turner, Bryan M
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2013
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3769143/
https://ncbi.nlm.nih.gov/pubmed/23634885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8935-6-11
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia